Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer

Published:2019-09 Issue:5 Volume:18 Page:583-588
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Vuolukka Kristiina,Auvinen Päivi,Palmgren Jan-Erik,Voutilainen Tuuli,Aaltomaa Sirpa,Kataja Vesa

Funder

Instrumentarium Science Foundation

Finnish Cancer Foundation

Kuopio University Hospital

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference26 articles.

1. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality;Kollmeier;Int J Radiat Oncol Biol Phys,2003

3. Brachytherapy for prostate cancer: A systematic review of clinical and cost effectiveness;Norderhaug;Eur Urol,2003

4. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: A systematic review of randomised and nonrandomised controlled clinical trials;Peinemann;Eur Urol,2011

5. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer;Hunter;Prostate Cancer,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020;Clinical and Translational Radiation Oncology;2024-09

2. BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer;Cancers;2023-08-11

3. Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy;Cancers;2023-08-10

4. Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2023-04-24

5. Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system;Prostate International;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3